Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis

Carla Winter, Carlos Silvestre-Roig, Almudena Ortega-Gomez, Patricia Lemnitzer, Hessel Poelman, Ariane Schumski, Janine Winter, Maik Drechsler, Renske de Jong, Roland Immler, Markus Sperandio, Michael Hristov, Tanja Zeller, Gerry A. F. Nicolaes, Christian Weber, Joana R. Viola, Andres Hidalgo, Christoph Scheiermann, Oliver Soehnlein

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)175-182.e5
Number of pages13
JournalCell Metabolism
Volume28
Issue number1
DOIs
Publication statusPublished - 3 Jul 2018

Keywords

  • MYOCARDIAL-INFARCTION
  • CIRCADIAN CLOCK
  • RECRUITMENT
  • LEUKOCYTE
  • CCR2
  • HYPERLIPIDEMIA
  • EXPRESSION
  • MONOCYTES
  • LY6C(HI)
  • ADHESION

Cite this

Winter, C., Silvestre-Roig, C., Ortega-Gomez, A., Lemnitzer, P., Poelman, H., Schumski, A., Winter, J., Drechsler, M., de Jong, R., Immler, R., Sperandio, M., Hristov, M., Zeller, T., Nicolaes, G. A. F., Weber, C., Viola, J. R., Hidalgo, A., Scheiermann, C., & Soehnlein, O. (2018). Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis. Cell Metabolism, 28(1), 175-182.e5. https://doi.org/10.1016/j.cmet.2018.05.002